[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368792-105":59,"doc-detail-368792-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","construction-of-a-genetic-prognostic-model-in-the-glioblastoma-tumor-microenvironment","Construction of a Genetic Prognostic Model in the Glioblastoma Tumor Microenvironment","","Glioblastoma (GBM) remains among the most challenging malignancies, with poor clinical outcomes and severely impaired patient wellbeing. The immunological landscape in the tumor microenvironment (TME) is crucial for GBM prognosis, motivating identification of immune-related genes with prognostic potential. Data were mined from TCGA and GEO, using ESTIMATE and xCell to score gene expression profiles and CIBERSORT to estimate immune cell subpopulations. GSE16011 served as the training set, while lasso regression, Cox analysis, and random forest were used to build a prognostic model. A nomogram was optimized and validated using GSE7696 and TCGA-GBM, followed by mutation and enrichment analyses. Six genes (MEOX2, PHYHIP, RBBP8, ST18, TCF12, THRB) formed the final prognostic model, with Kaplan–Meier analysis showing strong prognostic performance. Prognostic modeling based on TME and immune-score stratification supports GBM risk assessment.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/construction-of-a-genetic-prognostic-model-in-the-glioblastoma-tumor-microenvironment/368792/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/construction-of-a-genetic-prognostic-model-in-the-glioblastoma-tumor-microenvironment/368792.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of this study?","Question",{"text":113,"@type":114},"To construct a genetic prognostic model for glioblastoma based on tumor microenvironment immune features and assess its prognostic value.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which datasets were used for training and validation?",{"text":118,"@type":114},"GSE16011 was used as the training set, and GSE7696 and TCGA-GBM were used as validation sets.",{"name":120,"@type":111,"acceptedAnswer":121},"How were immune-related gene expression and immune cell infiltration evaluated?",{"text":122,"@type":114},"Gene expression profiles were scored by ESTIMATE and xCell, immune cell subpopulations were analyzed using CIBERSORT, and immune-score-associated profiles were used for model building.",{"name":124,"@type":111,"acceptedAnswer":125},"Which genes were included in the final prognostic model?",{"text":126,"@type":114},"The final model was based on six genes: MEOX2, PHYHIP, RBBP8, ST18, TCF12, and THRB.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},368792,1790222350,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":31,"preview_page_count":19,"preview_urls":149},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nConstruction of a Genetic Prognostic Model in the Glioblastoma Tumor Microenvironment  \nWenhui Wu 1,2,†, Wenhao Liu 1,2,†, Zhonghua Liu 1, * and Xin Li 1,2,3, *  \nAcademic Editors: Gael Roue and Ankush Chandra  \nReceived: 4 July 2025  \nRevised: 17 July 2025  \nAccepted: 22 July 2025  \nPublished: 24 July 2025  \nCitation: Wu, W.; Liu, W.; Liu, Z.; Li, X. Construction of a Genetic Prognostic Model in the Glioblastoma Tumor Microenvironment. Genes 2025, 16, 861. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes16080861  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 College of Life Science, Northeast Agricultural University, Harbin 150030, China;  \n[s220901080@neau.edu.cn](s220901080@neau.edu.cn) (W.W.); [b230901013@neau.edu.cn](b230901013@neau.edu.cn) (W.L.)  \n2 State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China  \n3 Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China  \n* Correspondence: [liuzhonghua@neau.edu.cn](liuzhonghua@neau.edu.cn) (Z.L.); [xinli@ioz.ac.cn](xinli@ioz.ac.cn) (X.L.)† These authors contributed equally to this work.  \nAbstract  \nBackground: Glioblastoma (GBM) is one of the most challenging malignancies in all of neoplasms. These malignancies are associated with unfavorable clinical outcomes and significantly compromised patient wellbeing. The immunological landscape within the tumor microenvironment (TME) plays a critical role in determining GBM prognosis. By mining data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases and correlating them with immune responses in the TME, genes associated with the immune microenvironment with potential prognostic value were obtained. Method: We selected GSE16011 as the training set. Gene expression profiles were substrates scored by both ESTIMATE and xCell, and immune cell subpopulations in GBM were analyzed by CIBERSORT. Gene expression profiles associated with low immune scores were performed by lasso regression, Cox analysis and random forest (RF) to identify a prognostic model for the multiple genes associated with immune infiltration in GBM. Then we constructed anomogram to optimize the prognostic model using GSE7696 and TCGA-GBM as validation sets and evaluated these data for gene mutation and gene enrichment analysis. Result: The prognostic correlation between the six genes (MEOX2, PHYHIP, RBBP8, ST18, TCF12, and THRB) and GBM was finally found by lasso regression, Cox regression, and RF, and the online database obtained that all six genes were differentially expressed in GBM. Therefore, a prognostic correlation model was constructed based on the six genes. Kaplan–Meier (KM) survival analysis showed that this prognostic model had excellent prognostic ability. Conclusions: Prognostic models based on tumor microenvironment and immune score stratification and the construction of related genes have potential applications for prognostic analysis of GBM patients.  \nKeywords: glioblastoma; tumor microenvironment; nomogram; prognosis  \n1. Introduction  \nGlobal incidence of central nervous system (CNS) malignancies demonstrated a sustained increase between 1990 and 2016 . In 2016, brain and CNS tumors affected roughly 330,000 individuals, resulting in 227,000 fatalities [1] . GBM, a CNS tumor, represents the most common primary malignant brain cancer [2,3] . GBM currently has multiple therapeutic approaches, yet clinical outcomes remain unfavorable, demonstrating merely a 5.5% five-year survival probability [4,5] . Consequently, identification of potential GBM  \nbiomarkers through clinical expression pr","cbCaif4jt9naiL9Z","https://ap.wps.com/l/cbCaif4jt9naiL9Z","pdf",6712057,"English","# Introduction\n## Background on glioblastoma and prognosis\n## Tumor microenvironment interactions\n## Immune infiltration quantification methods","[{\"question\":\"What is the main goal of this study?\",\"answer\":\"To construct a genetic prognostic model for glioblastoma based on tumor microenvironment immune features and assess its prognostic value.\"},{\"question\":\"Which datasets were used for training and validation?\",\"answer\":\"GSE16011 was used as the training set, and GSE7696 and TCGA-GBM were used as validation sets.\"},{\"question\":\"How were immune-related gene expression and immune cell infiltration evaluated?\",\"answer\":\"Gene expression profiles were scored by ESTIMATE and xCell, immune cell subpopulations were analyzed using CIBERSORT, and immune-score-associated profiles were used for model building.\"},{\"question\":\"Which genes were included in the final prognostic model?\",\"answer\":\"The final model was based on six genes: MEOX2, PHYHIP, RBBP8, ST18, TCF12, and THRB.\"}]","Construction of a Genetic Prognostic Model in the Glioblastoma Tumor Microenvironment | PDF",1790178567,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fef5627e65a0d4b45ea0be95af22b3b1.webp",983,1390,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab35097177efc6a20a87203d9def82ba.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4802ba920ed9a8bbde8ff47bb2f420df.webp",981,1387,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b291d0504e56656bda814acc942121e.webp",980,1385]